The research behind the Supplement Guide and PMOS Connections cards in the app — every summary here is backed by a real, peer-reviewed citation, listed in full at the bottom of the page.
This is educational information, not medical advice. Nothing on this page diagnoses PMOS or replaces a conversation with a qualified healthcare provider. Evidence strength varies by topic — each entry says so directly rather than overstating what the research supports.
Eleven supplements that come up most often in PMOS research, each with what the evidence actually supports and what to know before starting one. This isn’t a recommendation to take any of these — talk to your provider first, especially if you’re on other medications.
Myo-inositol is a naturally occurring compound involved in insulin signalling. Multiple clinical trials have found it can improve insulin sensitivity, reduce androgen levels, and support more regular ovulation in people with PMOS. A 40:1 ratio of myo-inositol to D-chiro-inositol is often cited as matching the body's natural ratio.
Generally well tolerated. Mild digestive upset is the most common side effect. May take 3–6 months to see full effect. If you are taking metformin, let your provider know as both affect insulin pathways.
Magnesium deficiency is common in people with PMOS and insulin resistance. Research suggests magnesium supplementation may help improve insulin sensitivity, reduce inflammatory markers, ease anxiety, and support sleep quality – all areas frequently affected by PMOS.
Magnesium glycinate or malate are generally better tolerated than magnesium oxide. High doses can cause loose stools. Take in the evening as it can promote relaxation.
Studies consistently show higher rates of vitamin D deficiency in people with PMOS compared to the general population. Vitamin D receptors are present in ovarian tissue, and supplementation has been explored for its effects on menstrual regularity, insulin resistance, and mood. Low vitamin D is also linked to increased depression risk.
Get your levels tested before supplementing – dosing depends on your baseline. Vitamin D is fat-soluble, so take it with a meal containing fat. D3 (cholecalciferol) is more effective than D2 at raising blood levels.
Omega-3 fatty acids (EPA and DHA) have anti-inflammatory effects that are well established in general research. In PMOS-specific studies, omega-3 supplementation has shown promise for reducing testosterone levels, improving insulin resistance, and lowering triglycerides, though the trial base is smaller than for inflammation broadly. Evidence for omega-3 supporting mood and easing depressive symptoms is more established.
Look for a supplement with at least 1g combined EPA + DHA. Can cause fishy burps – refrigerating the capsules can help. If you are on blood thinners, speak with your provider before supplementing.
NAC is a precursor to glutathione, the body's master antioxidant. Some clinical trials in people with PMOS suggest it can improve insulin sensitivity, reduce androgen levels, and support ovulation, with a few smaller studies finding outcomes comparable to metformin on certain measures – though the evidence base for NAC is considerably thinner than for metformin itself. It has also been studied, separately, for its effects on mood and OCD-spectrum symptoms.
Generally well tolerated. Nausea is the most common side effect. Do not take with nitroglycerin or activated charcoal. May interact with some blood pressure medications.
Berberine activates AMPK, the same metabolic pathway targeted by metformin. Studies in people with PMOS have found it can improve insulin sensitivity, reduce androgens, lower LDL cholesterol, and support more regular cycles. Some trials have directly compared it to metformin with similar outcomes.
Should not be combined with metformin without medical supervision as both have overlapping mechanisms. Can cause digestive upset, especially at first. Not recommended during pregnancy. Interacts with some medications – check with your provider.
Zinc plays a role in insulin signalling, hormone regulation, and immune function. In PMOS research, zinc supplementation has been associated with reductions in acne, improvements in hirsutism (unwanted hair growth), and lower androgen levels. Zinc also inhibits 5-alpha reductase, the enzyme that converts testosterone to its more potent form.
Long-term high-dose zinc can deplete copper – if supplementing for more than a few weeks, consider a zinc/copper combination. Take with food to reduce nausea. 25–40mg elemental zinc per day is the typical range studied.
A small number of clinical studies suggest spearmint may have mild anti-androgenic effects. Two cups of spearmint tea per day (or an equivalent supplement) have been associated with reduced free testosterone levels and improved self-reported hirsutism scores in people with PMOS in these studies, though trials are few and small. It is one of the gentler, better-tolerated options for androgen-related symptoms.
Tea form is most studied – two cups of brewed spearmint tea daily. Supplement standardisation varies. Effects are modest and may take 4–8 weeks to notice. Generally very safe.
Coenzyme Q10 is essential for cellular energy production and acts as an antioxidant in cell membranes, including egg cells. Research in people with PMOS has explored CoQ10 for improving egg quality, particularly relevant for those pursuing fertility. Some studies also suggest it may improve insulin sensitivity.
Ubiquinol form is better absorbed than ubiquinone. Fat-soluble – take with a meal. Generally well tolerated. Most fertility-focused studies use 200–600mg daily.
Heavy or prolonged periods – common in PMOS – can lead to iron deficiency or iron deficiency anaemia. Symptoms include fatigue, brain fog, shortness of breath, and poor concentration, which can overlap with and worsen PMOS symptoms. Monitoring iron (including ferritin, not just haemoglobin) is worthwhile if your periods are heavy.
Only supplement if you have confirmed deficiency – excess iron is harmful. Iron bisglycinate or ferrous bisglycinate is better tolerated and causes less constipation than ferrous sulfate. Take with vitamin C to improve absorption; avoid taking with calcium, tea, or coffee.
B vitamins play a central role in energy metabolism, mood regulation, and methylation – a biochemical process affecting hormones, neurotransmitters, and DNA repair. B6 in particular has been studied for PMS symptoms and progesterone support. Folate (as methylfolate rather than folic acid) is especially important for those planning pregnancy. Some people with PMOS carry MTHFR gene variants that affect folate metabolism.
A B-complex covering B6, B12, and methylfolate is often preferred over individual supplements. B6 nerve damage (peripheral neuropathy) has been reported at doses well below what was once considered safe for long-term use – some regulators now set daily upper limits for ongoing supplementation as low as 10–12mg, far under older 200mg guidance. Don't exceed the dose on the label without your provider's input, and avoid high-dose B6 supplements taken daily for months at a time. Look for methylated forms (methylcobalamin, methylfolate) for better bioavailability.
PMOS is a multisystem condition — it doesn’t stay confined to cycles and ovaries. Here’s what the research says about how it relates to metabolic, mental, and cardiovascular health, split by how settled the evidence is.
Insulin resistance – needing more insulin than usual to keep blood sugar normal – affects most people with PMOS, independent of body weight. It's one of the more settled findings in PMOS research: the 2023 International PCOS Guideline recommends screening for it regardless of BMI.
Two visible signs are classic markers: acanthosis nigricans (dark, velvety skin at the neck, underarms, or groin) and skin tags in the same areas. Neither diagnoses insulin resistance alone – that takes bloodwork (fasting glucose, fasting insulin, or HOMA-IR) – but both are worth mentioning to a provider, especially alongside weight changes or post-meal energy crashes.
Anxiety and moderate-to-severe depressive symptoms are markedly more common in PMOS than in the general population – one of the most consistently replicated findings in PMOS research. A 2017 meta-analysis pooling dozens of studies found both roughly three times as common in people with PMOS, holding even after accounting for BMI in most included studies.
The mechanism isn't fully settled – insulin resistance, chronic inflammation, elevated androgens, and the burden of a chronic, often-dismissed condition likely all play a role – but the association itself is well established. Both are treatable, and PMOS-related depression responds to the same treatments as depression generally.
Obstructive sleep apnea (OSA) – repeated pauses in breathing during sleep that fragment rest and drop blood oxygen overnight – is dramatically more common in PMOS. A 2025 meta-analysis found PMOS associated with roughly 9–10x higher odds of OSA, with prevalence reaching 37% in PMOS versus 6% in comparison groups, and risk rising further with higher BMI and insulin resistance.
OSA often goes undiagnosed because its main signs – loud snoring, gasping or choking during sleep, and daytime fatigue despite a full night in bed – get written off as “just being tired.” It's diagnosed with a sleep study and is treatable, so worth raising if it sounds familiar.
Autoimmune thyroid disease – most often Hashimoto's thyroiditis, where the immune system gradually attacks the thyroid – occurs more often in PMOS than in the general population. A 2022 meta-analysis found significantly higher odds of Hashimoto's in people with PMOS (about 2.3x), and the two conditions share overlapping symptoms – fatigue, weight changes, irregular cycles, mood shifts – which can blur which condition is driving what.
Because an underactive thyroid can independently cause irregular cycles, most PMOS diagnostic workups include a TSH test partly to rule this in or out. If you haven't had your thyroid checked, it's worth raising with your provider, especially if fatigue or weight changes feel out of proportion to what you'd expect.
PMOS carries a higher lifetime risk of cardiovascular disease, which is why PMOS management includes cardiovascular screening at every life stage, not just a metabolic side note. The meta-analysis behind the 2023 International Evidence-based PCOS Guideline Update found higher rates of clinical cardiovascular disease in people with PMOS (about 1.7x for combined cardiovascular events, and roughly 2.5x for heart attack specifically), above and beyond what's explained by BMI alone.
The mechanism ties back to PMOS-associated risk factors compounding together: insulin resistance, higher rates of high blood pressure and unfavorable cholesterol patterns, and chronic low-grade inflammation – which is why the 2023 guideline recommends screening regardless of weight.
Chronic anovulation – cycles where ovulation doesn't happen, common in PMOS – means the uterine lining can build up for months without shedding, which raises the risk of endometrial hyperplasia and, over time, endometrial cancer. A 2022 updated meta-analysis found PMOS associated with roughly 3.7x higher odds of endometrial cancer compared to people without PMOS.
This is one of the clearest, most practical reasons irregular or absent periods in PMOS are worth actively addressing with a provider (through hormonal regulation, progesterone therapy, or other options), not just monitored.
Estrogen and dopamine are known to interact – estrogen supports dopamine signaling, the same pathway ADHD medications target. Because estrogen drops in the days before your period, some people notice focus, emotional regulation, or impulsivity feel harder premenstrually, easing again once estrogen rises in the follicular phase. This pattern shows up in general menstrual-cycle and PMDD research; it isn't something that's been shown to be unique to PMOS.
Separately, there's a real research literature linking PMOS during pregnancy to higher rates of ADHD and autism diagnoses in children – a different question from whether having PMOS yourself raises your own odds of having ADHD, where evidence is much thinner (mostly small studies). We're not citing a specific multiplier here, and you shouldn't take one as established fact if you see it elsewhere.
This is an active, evolving area of research rather than settled science – useful for spotting your own patterns, not a substitute for a professional ADHD evaluation.
Histamine and estrogen appear to influence each other: estrogen can stimulate mast cells to release histamine, and histamine may in turn prompt the ovaries to produce more estrogen. For people with PMOS, who often already run higher estrogen relative to progesterone, this feedback loop is a biologically plausible way that hormonal and histamine-type symptoms could reinforce one another.
That said, this loop is mostly discussed in integrative and functional-medicine sources rather than confirmed in peer-reviewed PMOS-specific clinical research – and it isn't unique to PMOS either; the same mechanism comes up in general menstrual-cycle, perimenopause, and mast-cell-activation discussions.
Symptoms to watch for: skin flushing, hives, a racing heart, headaches, runny nose, and bloating after eating, particularly after high-histamine foods like aged cheese, wine, fermented foods, or leftover meat. Some people notice these flare around ovulation and again premenstrually.
Every reference below links to an actual paper, systematic review, or clinical database entry — nothing here is invented or paraphrased from a secondary source.